首页> 外文期刊>Urology >Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.
【24h】

Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.

机译:用于前列腺癌检测的胰岛素样生长因子1(IGF-1),IGF-1密度和IGF-1 / PSA比。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: Recent studies suggest an association between increased serum levels of insulin-like growth factor 1 (IGF-1) and an increased risk of prostate cancer (PCa). We prospectively analyzed the value of IGF-1, IGF-density (IGFD), and IGF-1/prostate-specific antigen (PSA) ratio for early detection of prostate cancer. METHODS: IGF-1, IGFD, and IGF-1/PSA ratio were determined prospectively during an 11-month period in the serum from 245 consecutive white men with PSA levels between 2.5 and 15 ng/mL. Octant biopsy (including transition zone biopsy) was performed. A second biopsy was performed 6 weeks later if the first biopsy was negative. Prostate volume was measured using transrectal ultrasound and the prolate ellipsoid method. Receiver operating characteristic curves were performed to compare tests. RESULTS: No evidence of malignancy was found in 174 patients (71%), and PCa was found in 71 (29%). The mean age for patients with no evidence of malignancy and those with PCa was 67.7+/-9 and 65.7+/-6 years, respectively (P = 0.17). IGF-1, IGFD, IGF-1/PSA ratio, and PSA were significantly higher in patients with PCa than in those with benign disease (P = 0.03, P = 0.045, P = 0.001, and P = 0.018, respectively). The area under the curve value derived from the receiver operating characteristic curves for IGF-1/PSA ratio, PSA, IGFD, and IGF-1 was 71%, 61%, 60%, and 58%, respectively. At 95% sensitivity, the specificity of the IGF-1/PSA ratio was significantly greater than that of all other parameters (P<0.0001 ). An IGF-1/PSA cutoff value of 25 afforded a 95% sensitivity for detecting PCa and would have avoided unnecessary biopsies in 24.1% of patients. CONCLUSIONS: Although IGF-1 and IGFD were unable to enhance the performance of PSA in our study, the IGF-1/PSA ratio significantly improved PCa detection over the use of PSA alone. Thus, increased IGF-1 levels (i.e., the IGF-1/PSA ratio) may not only be associated with an increased PCa risk but may also be a useful tool for early detection.
机译:目的:最近的研究表明,血清胰岛素样生长因子1(IGF-1)水平升高与前列腺癌(PCa)风险增加之间存在关联。我们前瞻性地分析了IGF-1,IGF密度(IGFD)和IGF-1 /前列腺特异性抗原(PSA)比值对前列腺癌早期检测的价值。方法:前瞻性地测定了11个月内来自245名连续PSA水平在2.5至15 ng / mL之间的白人男性血清中的IGF-1,IGFD和IGF-1 / PSA比率。进行octant活检(包括过渡区活检)。如果第一次活检阴性,则在6周后进行第二次活检。使用经直肠超声和长椭球方法测量前列腺体积。进行接收器工作特性曲线以比较测试。结果:174例患者(71%)未发现恶性肿瘤,71例(29%)未发现PCa。无恶性肿瘤患者和PCa患者的平均年龄分别为67.7 +/- 9岁和65.7 +/- 6岁(P = 0.17)。 PCa患者的IGF-1,IGFD,IGF-1 / PSA比和PSA明显高于良性疾病患者(分别为P = 0.03,P = 0.045,P = 0.001和P = 0.018)。从接收器工作特性曲线得出的IGF-1 / PSA比,PSA,IGFD和IGF-1的曲线值下的面积分别为71%,61%,60%和58%。在灵敏度为95%时,IGF-1 / PSA比的特异性明显高于所有其他参数(P <0.0001)。 IGF-1 / PSA截止值为25,可提供95%的灵敏度检测PCa,并且可以避免24.1%的患者进行不必要的活检。结论:尽管IGF-1和IGFD不能增强PSA的性能,但与单独使用PSA相比,IGF-1 / PSA的比例可显着改善PCa的检测。因此,增加的IGF-1水平(即,IGF-1 / PSA比)不仅可能与增加的PCa风险有关,而且可能是早期检测的有用工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号